Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...

The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year ...

Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...

根据美国证券交易委员会的Form 4文件显示，总部位于特拉华州的投资公司Focused Compounding Fund, LP近期大举增持Parks America, Inc. (OTC: PRKA )普通股。该基金以每股0.35美元的价格购入867,514股，总投资额约为303,629美元。目前该股票交易价格为0.41美元，根据 InvestingPro 的公允价值分析，当前估值偏高。

Eli Lilly announced a price reduction for its weight-loss drug Zepbound's vials by $50 or more, adapting to stiff competition ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

With its Bitcoin-in, Bitcoin-out model, Acre simplifies compounding for BTC holders while empowering decentralized networks ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...